496 related articles for article (PubMed ID: 32233339)
21. Osteogenic potential of induced pluripotent stem cells from human adipose-derived stem cells.
Mao SH; Chen CH; Chen CT
Stem Cell Res Ther; 2019 Oct; 10(1):303. PubMed ID: 31623672
[TBL] [Abstract][Full Text] [Related]
22. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
23. Expression level of pluripotent genes in incomplete reprogramming.
Zhao X; Li Q; Jiang WM; Liu HY; Ma N; Zhou Z; Li LJ; Huang YH; Ma YL
Asian Pac J Trop Med; 2014 Aug; 7(8):639-644. PubMed ID: 25149378
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
25. Human adipose tissue-derived SSEA-4 subpopulation multi-differentiation potential towards the endothelial and osteogenic lineages.
Mihaila SM; Frias AM; Pirraco RP; Rada T; Reis RL; Gomes ME; Marques AP
Tissue Eng Part A; 2013 Jan; 19(1-2):235-46. PubMed ID: 22924692
[TBL] [Abstract][Full Text] [Related]
26. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
27. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
[TBL] [Abstract][Full Text] [Related]
28. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
Pu L; Meng M; Wu J; Zhang J; Hou Z; Gao H; Xu H; Liu B; Tang W; Jiang L; Li Y
Stem Cell Res Ther; 2017 Mar; 8(1):72. PubMed ID: 28320452
[TBL] [Abstract][Full Text] [Related]
29. piggyBac Transposon Mediated Reprogramming and Flow Cytometry Analysis of CD44 and ICAM1 Cell-Surface Marker Changes.
Brightwell S; Kaji K
Methods Mol Biol; 2016; 1357():285-93. PubMed ID: 25410291
[TBL] [Abstract][Full Text] [Related]
30. Inducing Pluripotency in the Domestic Cat (
Dutton LC; Dudhia J; Guest DJ; Connolly DJ
Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming of Extraembryonic Trophoblast Stem Cells into Embryonic Pluripotent State by Fusion with Embryonic Stem Cells.
Hong YJ; Hong K; Byun S; Choi HW; Do JT
Stem Cells Dev; 2018 Oct; 27(19):1350-1359. PubMed ID: 29993328
[TBL] [Abstract][Full Text] [Related]
32. Efficient reprogramming of naïve-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system.
Zhang Y; Wei C; Zhang P; Li X; Liu T; Pu Y; Li Y; Cao Z; Cao H; Liu Y; Zhang X; Zhang Y
PLoS One; 2014; 9(1):e85089. PubMed ID: 24465482
[TBL] [Abstract][Full Text] [Related]
33. Induction of Expandable Adipose-Derived Mesenchymal Stem Cells from Aged Mesenchymal Stem Cells by a Synthetic Self-Replicating RNA.
Miyagi-Shiohira C; Nakashima Y; Kobayashi N; Kitamura S; Saitoh I; Watanabe M; Noguchi H
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404192
[TBL] [Abstract][Full Text] [Related]
34. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation plasticity of human adipose-derived stem cells in lineage commitment.
Berdasco M; Melguizo C; Prados J; Gómez A; Alaminos M; Pujana MA; Lopez M; Setien F; Ortiz R; Zafra I; Aranega A; Esteller M
Am J Pathol; 2012 Dec; 181(6):2079-93. PubMed ID: 23031258
[TBL] [Abstract][Full Text] [Related]
36. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
[TBL] [Abstract][Full Text] [Related]
37. Early reprogramming regulators identified by prospective isolation and mass cytometry.
Lujan E; Zunder ER; Ng YH; Goronzy IN; Nolan GP; Wernig M
Nature; 2015 May; 521(7552):352-6. PubMed ID: 25830878
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
[TBL] [Abstract][Full Text] [Related]
40. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
